Bellerophon to Present at the Jefferies Virtual Healthcare Conference

Rhea-AI Summary

Bellerophon Therapeutics (Nasdaq: BLPH) announces CEO Fabian Tenenbaum will present a corporate overview at the Jefferies Virtual Healthcare Conference from June 1-4, 2021. The presentation is scheduled for June 3, 2021, at 3:00 PM Eastern Time. Bellerophon focuses on innovative treatments for cardiopulmonary diseases, currently developing multiple candidates under its proprietary INOpulse® program. A live audio webcast and replay will be available on the Company’s website, providing investors with real-time access to this key event.

News Market Reaction – BLPH

-0.23%

-0.23% Session move

In the trading session that priced this news, BLPH declined 0.23%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WARREN, N.J., May 27, 2021 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced that Fabian Tenenbaum, Chief Executive Officer, will present a corporate overview at the Jefferies Virtual Healthcare Conference, being held June 1-4, 2021.

Presentation Details

Date:	Thursday, June 3, 2021
Time:	3:00 PM Eastern Time

A live audio webcast and replay of the presentation will be available in the Investors section on the Company’s website at www.bellerophon.com.

About Bellerophon
Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The Company is currently developing multiple product candidates under its INOpulse^® program, a proprietary pulsatile nitric oxide delivery system. For more information, please visit www.bellerophon.com.

Contacts
LifeSci Advisors:
Brian Ritchie
(212) 915-2578
britchie@lifesciadvisors.com

FAQ

When will Bellerophon Therapeutics present at the Jefferies Virtual Healthcare Conference?

Bellerophon Therapeutics will present on June 3, 2021, at 3:00 PM Eastern Time.

Who is presenting for Bellerophon Therapeutics at the Jefferies Conference?

CEO Fabian Tenenbaum will present for Bellerophon Therapeutics.

What is the focus of Bellerophon Therapeutics?

Bellerophon Therapeutics focuses on developing treatments for cardiopulmonary diseases.

Where can I access the presentation by Bellerophon Therapeutics?

The presentation will be available as a live audio webcast and replay on the Company's website.

What is the stock symbol for Bellerophon Therapeutics?

The stock symbol for Bellerophon Therapeutics is BLPH.